As cellular therapy products often cross international borders, it is important to be aware of applicable regulations in other regions. Products shipped across international borders must meet regulatory requirements of the competent authority of the exporting and importing country. Information on some non-U.S. competent authorities can be accessed via the links provided below. The information for each country is meant to serve as a resource, not a substitute for regulatory information or legal advice. Additionally, the information on this page is not updated in real-time, please contact the relevant competent authority to receive the most up-to-date information.
FDA to Host Virtual Town Hall on Gene Therapy Manufacturing
September 11, 2025
CMS to Join AABB eCast on Cellular Therapies Coding and Reimbursement
September 10, 2025
AABB Case Study Highlights CABP Credential’s Impact Across Biotherapies
September 10, 2025